MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-20-2026
Sintx Technologies Total Assets 2011-2026 | SINT
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Sintx Technologies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.51 M | 9.41 M | 15.4 M | 15.8 M | 21.8 M | 30.4 M | 9.15 M | 11.5 M | 14.6 M | 26.3 M | 36.5 M | 47.6 M | 34.3 M | 33.5 M | 61.2 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 61.2 M | 9.15 M | 25.1 M |
Quarterly Total Assets Sintx Technologies
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.4 M | 9.2 M | 11.4 M | 9.41 M | 11.3 M | 15.3 M | 17.6 M | 15.4 M | - | 19.1 M | 22.7 M | 15.8 M | 14.6 M | 17.5 M | 18.9 M | 21.8 M | 24.9 M | 26.4 M | 28.7 M | 30.4 M | 30.4 M | 30.4 M | 30.4 M | 9.15 M | 9.15 M | 9.15 M | 9.15 M | 11.5 M | 11.5 M | 11.5 M | 11.5 M | 14.6 M | 14.6 M | 14.6 M | 14.6 M | 26.3 M | 26.3 M | 26.3 M | 26.3 M | 35.9 M | 35.9 M | 35.9 M | 35.9 M | 47.6 M | 47.6 M | 47.6 M | 47.6 M | 34.3 M | 34.3 M | 34.3 M | 34.3 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 47.6 M | 9.15 M | 23 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
91.5 M | $ 3.71 | -5.12 % | $ 138 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Profound Medical Corp.
PROF
|
43.9 M | $ 5.82 | 13.01 % | $ 180 M |  Canada |
 |
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | USA |
 |
BioSig Technologies
BSGM
|
842 K | - | 37.08 % | $ 85.7 M | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 9.2 | 2.45 % | $ 330 M | USA |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
41.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 37.08 | 1.42 % | $ 1.15 B | USA |
 |
Smith & Nephew plc
SNN
|
10.4 B | - | - | $ 23.8 B |  Britain |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Electromed
ELMD
|
53.8 M | $ 24.66 | -0.16 % | $ 208 M | USA |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Helius Medical Technologies
HSDT
|
7.69 M | $ 2.16 | 7.46 % | $ 1.31 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M | Canada |
 |
Integra LifeSciences Holdings Corporation
IART
|
4.04 B | $ 9.55 | 0.1 % | $ 735 M | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
Inogen
INGN
|
299 M | $ 6.42 | 1.58 % | $ 171 M | USA |
 |
IRIDEX Corporation
IRIX
|
34.4 M | $ 1.33 | -1.85 % | $ 21.5 M | USA |
 |
IRadimed Corporation
IRMD
|
109 M | $ 101.78 | 0.8 % | $ 1.29 B | USA |
 |
Cytosorbents Corporation
CTSO
|
47.4 M | $ 0.67 | -3.52 % | $ 36.5 M | USA |
 |
Aethlon Medical
AEMD
|
7.36 M | $ 2.32 | 7.41 % | $ 3.62 M | USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
LivaNova PLC
LIVN
|
2.61 B | $ 63.3 | 1.44 % | $ 3.45 B | Britain |
 |
InspireMD
NSPR
|
69.4 M | $ 1.77 | -1.12 % | $ 114 M | Israel |
 |
LENSAR
LNSR
|
66.3 M | $ 5.58 | 0.36 % | $ 64.3 M | USA |
 |
AdaptHealth Corp.
AHCO
|
4.32 B | $ 11.39 | -0.78 % | $ 1.54 B | USA |
 |
Penumbra
PEN
|
1.83 B | $ 336.27 | 0.63 % | $ 13.1 B | USA |
 |
Medtronic PLC
MDT
|
91.7 B | $ 87.89 | 1.51 % | $ 113 B | USA |
 |
MiMedx Group
MDXG
|
343 M | $ 4.1 | -0.73 % | $ 606 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
210 M | $ 2.29 | -4.58 % | $ 134 M | Israel |
 |
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 16.23 | 2.01 % | $ 381 M | USA |
 |
Myomo
MYO
|
38.6 M | $ 0.7 | -0.1 % | $ 29.3 M | USA |
 |
NanoVibronix
NAOV
|
3.63 M | - | - | $ 1.08 M | USA |
 |
Inspire Medical Systems
INSP
|
907 M | $ 51.41 | -1.27 % | $ 1.51 B | USA |
 |
Orthofix Medical
OFIX
|
851 M | $ 11.93 | 1.79 % | $ 472 M |  Curacao |